14 days ago
SYRE
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Sectors:
Industries:
Analyst Ranking
Top 2%
#102 out of 5263 analysts
Average Return
+40.78%
Win Rate
64%79 out of 124
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +370.11% | $14.82 | $69.67 | 2025-09-16 - 2026-04-24 | Strong Buy |
Climb Bio IncCLYM | +368.72% | $1.95 | $9.14 | 2025-10-16 - 2026-04-24 | Strong Buy |
Climb Bio IncCLYM | +354.73% | $2.01 | $9.14 | 2025-09-30 - 2026-04-24 | Strong Buy |
Oruka Therapeutics IncORKA | +325.85% | $16.21 | $69.03 | 2025-09-17 - 2026-04-24 | Strong Buy |
Climb Bio IncCLYM | +293.97% | $2.32 | $9.14 | 2025-09-22 - 2026-04-24 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
14 days ago
ORKA
a month ago
JBIO
3 months ago
NKTR
4 months ago
ARDX
4 months ago
ABVX
4 months ago
APGE
4 months ago
APGE
5 months ago
TBPH
5 months ago
CGEM
5 months ago
RNAC
5 months ago
ORKA
7 months ago
ABVX
7 months ago
CLYM
7 months ago
MAZE
10 months ago
TBPH
a year ago
OTLK
2 years ago
VRDN
2 years ago
VRDN
2 years ago
PTGX
2 years ago
SYRE
3 years ago
CBAY
3 years ago
CBAY
3 years ago
CBAY
3 years ago
KROS
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | 5 | Strong Buy | $178.00 | +94.15% | Maintains | 7 days ago |
Spyre Therapeutics IncSYRE | 8 | Strong Buy | $98.00 | +40.66% | Maintains | 14 days ago |
Avalo Therapeutics IncAVTX | 4 | Strong Buy | $40.00 | +187.36% | Reiterates | 14 days ago |
Oruka Therapeutics IncORKA | 6 | Strong Buy | $78.00 | +12.99% | Maintains | 14 days ago |
Climb Bio IncCLYM | 4 | Strong Buy | $8.00 | -12.47% | Reiterates | 19 days ago |
Akebia Therapeutics IncAKBA | 5 | Strong Buy | $4.00 | +179.72% | Reiterates | 20 days ago |
Connect Biopharma Holdings LtdCNTB | 4 | Strong Buy | $10.00 | +296.83% | Reiterates | a month ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $15.00 | +383.87% | Reiterates | a month ago |
Moonlake ImmunotherapeuticsMLTX | 6 | Strong Buy | $30.00 | +74.62% | Reiterates | a month ago |
Maze Therapeutics IncMAZE | 6 | Strong Buy | $46.00 | +78.23% | Reiterates | a month ago |
Apogee Therapeutics IncAPGE | 6 | Strong Buy | $137.00 | +60.03% | Reiterates | a month ago |
Theravance Biopharma IncTBPH | 6 | Strong Buy | $21.00 | +27.58% | Reiterates | a month ago |
Jade Biosciences IncJBIO | 5 | Strong Buy | $39.00 | +56.12% | Maintains | a month ago |
Liquidia CorpLQDA | 7 | Strong Buy | $50.00 | +34.01% | Maintains | 2 months ago |
Innoviva IncINVA | 2 | Strong Buy | $35.00 | +48.49% | Reiterates | 2 months ago |
Abivax SaABVX | 5 | Strong Buy | $150.00 | +30.94% | Reiterates | 2 months ago |
Ardelyx IncARDX | 3 | Strong Buy | $17.00 | +185.71% | Reiterates | 2 months ago |
Mereo Biopharma Group PLCMREO | 3 | Strong Buy | $1.00 | +244.83% | Reiterates | 3 months ago |
Rezolute IncRZLT | 5 | Strong Buy | $5.00 | +61.29% | Reiterates | 4 months ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $38.00 | +187.44% | Maintains | 5 months ago |
Cartesian Therapeutics IncRNAC | 2 | Strong Buy | $44.00 | +551.85% | Maintains | 5 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $61.00 | +344.28% | Reiterates | 6 months ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $82.00 | -18.00% | Reiterates | 6 months ago |
Outlook Therapeutics IncOTLK | 4 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Aclaris Therapeutics IncACRS | 3 | Strong Buy | $8.00 | N/A | Upgrades | a year ago |
Vyne Therapeutics IncVYNE | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Anaptysbio IncANAB | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 3 years ago |
Cymabay Therapeutics IncCBAY | 7 | Strong Buy | $24.00 | N/A | Maintains | 3 years ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 3 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 4 years ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.